Myozyme er indiceret til langtids- enzymerstatningsterapi hos patienter med en bekræftet diagnose på Pompes sygdom (sur α- glukosidase- mangel).
Myozyme is indicated for long-term enzyme replacement therapy (ERT) in patients with a confirmed diagnosis of Pompe disease (acid α -glucosidase deficiency).